Yemen: The Supreme Authority for Medicines Announces the Start of Implementation of the New Official Price List

Arab Sea Newspaper - Special

Arabian Sea - Yemen - Follow-ups: The Supreme Authority for Medicines and Medical Supplies, in the interim capital Aden, announced today the start of implementing the new and approved official pricing for medicines in all local markets, starting today, Monday, August 25, 2025, as part of efforts to regulate the pharmaceutical market and ensure that citizens obtain medicines at fair and reasonable prices. In a statement, the Authority affirmed that this measure comes in response to directives issued by the Prime Minister and the decision of the Central Bank of Yemen regarding setting foreign exchange rates against the Yemeni rial, which directly affected the pricing of imported medicines and medical supplies. It pointed out that this step aims to reduce price manipulation and alleviate the economic burdens on citizens in light of the difficult conditions the country is going through. The Supreme Authority for Medicines clarified that the announced official pricing is binding on all pharmaceutical companies, local factories, importers, wholesalers, and pharmacies. It affirmed that it will work to monitor the full implementation of the new prices through its inspection and control teams in the interim capital Aden and the rest of the liberated governorates. The Authority also stressed that the new prices are reduced compared to previous periods, ensuring the availability of essential and necessary medicines at reasonable prices and achieving a balance between importers and consumers, in order to maintain market stability and ensure that treatment reaches patients without difficulty. The Authority indicated that any violation or refusal to comply with the official pricing will subject the perpetrators to legal procedures and deterrent penalties, calling on citizens to report any violations or attempts at exploitation through the official channels designated to receive complaints. In conclusion of its statement, the Authority reiterated that serving the citizen remains its top priority, and that it is continuing to implement its plans aimed at controlling the pharmaceutical market and enhancing transparency in a way that ensures the provision of high-quality medicines at fair prices, while praising the role of all its partners in this aspect from government agencies and the private sector.